|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C12N 15/88 | |
| C07C 321/14 | |||
| C07C 235/06 | |||
| C07C 271/16 | |||
| C07C 275/06 | |||
| A61K 9/127 | |||
| A61K 47/48 | |||
| A61K 48/00 | |||
| A61K 31/7088 | |||
| A61K 47/44 | |||
| C07H 21/00 | |||
| C07C 233/18 | |||
| C07C 235/08 |
| (11) | Patento numeris | 1664316 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04761838.4 |
| Europos patento paraiškos padavimo data | 2004-09-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-06-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-08-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2004/001677 |
| Data | 2004-09-15 |
| (87) | Numeris | WO 2005/026372 |
| Data | 2005-03-24 |
| (30) | Numeris | Data | Šalis |
| 503239 P | 2003-09-15 | US |
| (72) |
HEYES, James, CA
MACLACHLAN, Ian, CA
AMBEGIA, Ellen Grace, CA
|
| (73) |
Protiva Biotherapeutics Inc.,
100-8900 Glenlyon Parkway, Burnaby, British Columbia V5J 5J8,
CA
|
| (54) | POLYETHYLENEGLYCOL-MODIFIED LIPID COMPOUNDS AND USES THEREOF |
| POLYETHYLENEGLYCOL-MODIFIED LIPID COMPOUNDS AND USES THEREOF |